Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Sell
1,398
-36
-3% -$7.75K 0.23% 56
2026
Q1
$312K Sell
1,434
-245
-15% -$54.3K 0.23% 55
2025
Q4
$384K Buy
+1,679
New +$382K 0.28% 50

Other funds holding ABBV

Prota Financial's ABBV Position: Q2 2026 in Review

Prota Financial reduced its AbbVie (ABBV) stake by 2.5% in Q2 2026, selling an estimated $7.75K and leaving 1,398 shares worth $351K. The position accounts for 0.23% of the portfolio, ranked #56.

Prota Financial first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $384K in Q4 2025. 1,332 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Prota Financial held 1,398 shares of AbbVie worth $351K as of Q2 2026.
  • Prota Financial sold 36 AbbVie shares in Q2 2026, an estimated $7.75K.
  • AbbVie made up 0.23% of Prota Financial's portfolio in Q2 2026, its #56 holding.
  • Prota Financial first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Prota Financial's AbbVie position peaked at $384K in Q4 2025.
  • 1,332 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Prota Financial's 13F filing for Q2 2026, filed 7 Jul 2026.